CF
50
6
MAC
62
-3
SYY
52
11
HRL
30
-6
BMY
43
-3
FDX
39
-5
CA
10
-3
MRO
59
-3
CSCO
56
3
ESS
47
-4
PPL
52
-7
COP
48
-5
PYPL
39
-4
ITW
61
2
DAL
80
3
DTE
45
-2
JPM
62
2
CHRW
37
-13
SE
52
2
HSY
31
2
CF
50
6
MAC
62
-3
SYY
52
11
HRL
30
-6
BMY
43
-3
FDX
39
-5
CA
10
-3
MRO
59
-3
CSCO
56
3
ESS
47
-4
PPL
52
-7
COP
48
-5
PYPL
39
-4
ITW
61
2
DAL
80
3
DTE
45
-2
JPM
62
2
CHRW
37
-13
SE
52
2
HSY
31
2
Financhill
Back

Edesa Biotech 10K Form

Sell
1

EDSA
Edesa Biotech

Last Price:
2.51
Seasonality Move:
0.23%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive EDSA News And Ratings

See the #1 stock for the next 7 days that we like better than EDSA

EDSA Financial Statistics

Sales & Book Value

Annual Sales: $328.8K
Cash Flow: $-856.5K
Price / Cash Flow: 0
Annual Sales: $0.88
Price / Book: 2.91

Profitability

EPS (TTM): -2.19940
Net Income (TTM): $-6.93M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Edesa Biotech Earnings Forecast

Key Edesa Biotech Financial Ratios

  • The Selling, General & Administrative Expenses for EDSA have been equal to 1,028.77% of Gross Profit Margin.
  • The Interest Expense is -0.63% of Operating Income.
  • Per Share Earnings over the last 15 years have been positive in 4 years.

Edesa Biotech Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: EDSA
CUSIP: 27966L
Website: edesabiotech.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

EDSA Technical Analysis vs Fundamental Analysis

Sell
1
Edesa Biotech (EDSA) is a Sell

Is Edesa Biotech a Buy or a Sell?

  • Edesa Biotech stock is rated a Sell
    The current Edesa Biotech [EDSA] share price is $2.57. The Score for EDSA is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.